美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Fludrocortisone Acetate	Tablet			Refer to USP			2009/05/20
Fluoxetine	Capsules (Delayed Release)			Refer to USP			2007/07/25
Fluoxetine HCl	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fluoxetine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fluoxetine/Olanzapine	Capsule	II (Paddle)	50	0.1 N HCl	900	10, 20, 30 and 45	2006/08/17
Fluphenazine HCl	Tablet			Refer to USP			2017/11/02
Flutamide	Capsule			Develop a dissolution method			2024/01/03
Fluvastatin Sodium	Tablet (Extended Release)			Develop a dissolution method			2023/09/15
Fluvastatin Sodium	Capsule			Develop a dissolution method			2024/01/03
Fluvoxamine Maleate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fluvoxamine Maleate	Capsule (Extended Release)	II (Paddle)	50	Phosphate Buffer, pH 6.8	900	1, 2, 4, 6, 8 and 12 hours	2010/01/15
Fosamprenavir Calcium	Tablet	II (Paddle)	75	250 mM Sodium Acetate/Acetic acid buffer pH 3.5	900	10, 20, 30 and 45	2005/12/16
Fosamprenavir Calcium	Oral Suspension	II (Paddle)	25	10 mM HCl	900	5, 10,15 and 20	2007/12/03
Fosfomycin Tromethamine	For Suspension			Develop a dissolution method			2017/07/20
Fosinopril Sodium	Tablet			Develop a dissolution method			2023/09/15
Fosinopril Sodium/Hydrochlorothiazide	Tablet			Refer to USP			2008/08/11
Fostemsavir Tromethamine	Tablet (Extended Release	I (Basket)	100	0.05 M Phosphate Buffer, pH 6.8 buffer, pH 6.8	1000	1, 2, 3, 5, 7, 10, 12, 16, 20 and 24 hours	2021/08/19
Frovatriptan succinate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fruquintinib	Capsule	II (Paddle) with sinker	75	Phosphate-buffered saline (PBS), pH 6.8, w/ 0.08% SLS	900	5, 10, 15, 20, 30, 45 and 60	2025/09/08
Furosemide	Tablet			Refer to USP			2010/08/05